A study headed by IRB Barcelona provides the first direct evidence of beta-amyloid dimers (two proteins joined together) in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers.
Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
The new study analyses the dysfunction of basolateral transporters through a transgenic animal model.
This study is led by Manuel Palacín from IRB Barcelona and Virgínia Nunes from IDIBELL.
Yesterday IRB Barcelona’s Board of Trustees appointed the renowned scientist as director of the Institute, a position that he will take up on 1 May.
Francesc Posas succeeds Joan J. Guinovart, the director and founder of the Institute.
More than 75 scientists will be making their research projects known to the public.
IRB Barcelona will be participating through the workshop "Protein synthesis: Xenopus oocytes".
The IRB Barcelona scientist and head of the Colorectal Cancer Lab has been awarded the Olof Palme Medal in recognition of his recent discovery regarding the treatment of advanced-stage colon tumors with immunotherapy.
A study performed at IRB Barcelona supports the notion that mitochondrial defects underlie a set of diseases of unknown origin that involve chronic muscle inflammation.
Advanced Grants from the European Research Council (ERC) support researchers who have made important scientific achievements in the last 10 years.
The ICREA researcher at IRB Barcelona has been granted €2.5 M to continue his studies on the effects of diet on metastasis.
With this new award, the centre now holds 14 grants from the ERC.
The jury highlights the relevance of his findings for the cancer research field.
Font-Burgada has been Assistant Professor in the Cancer Biology Program at the Fox Chase Cancer Center in Philadelphia since 2017.
High-ranking figures from the business and innovation sectors attended an event organised by IRB Barcelona and ESADE with the aim to highlight the importance of uniting all sectors of society against metastasis.
Advances in research into the immunological evasion, metabolism and latency of metastatic cancer cells allow the identification of potential targets to test therapies.
IRB Barcelona and the BBVA Foundation invite 20 renowned international scientists working in the field of cancer metastasis to a gathering in Barcelona.
After the scientific conference, IRB Barcelona and ESADE have organised a debate on how to translate scientific research to society.